Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus
Open Access
- 3 August 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 2 (9) , pgad256
Abstract
Rubella is a highly contagious viral infection that usually causes a mild disease in children and adults. However, infection during pregnancy can result in a fetal or newborn death or congenital rubella syndrome (CRS), a constellation of permanent birth defects including cataracts, heart defects, and sensorineural deafness. The live-attenuated rubella vaccine has been highly effective, with the Americas declared free of endemic rubella transmission in 2015. However, rubella remains a significant problem worldwide and the leading cause of vaccine-preventable birth defects globally. Thus, elimination of rubella and CRS is a goal of the World Health Organization. No specific therapeutics are approved for the rubella virus. Therefore, we set out to identify whether existing small molecules may be repurposed for use against rubella virus infection. Thus, we performed a high-throughput screen for small molecules active against rubella virus in human respiratory cells and identified two nucleoside analogs, NM107 and AT-527, with potent antiviral activity. Furthermore, we found that combining these nucleoside analogs with inhibitors of host nucleoside biosynthesis had synergistic antiviral activity. These studies open the door to new potential approaches to treat rubella infections.Keywords
This publication has 25 references indexed in Scilit:
- Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiencyAntiviral Research, 2017
- Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika VirusCell Reports, 2017
- Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficienciesJournal of Allergy and Clinical Immunology, 2016
- Persistent Infection of Human Fetal Endothelial Cells with Rubella VirusPLOS ONE, 2013
- RubellaPediatrics in Review, 2010
- Combinations of Cyclophilin Inhibitor NIM811 with Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of ResistanceAntimicrobial Agents and Chemotherapy, 2008
- RubellaSeminars in Fetal and Neonatal Medicine, 2007
- Nucleoside Analog Inhibitors of Hepatitis C Virus ReplicationInfectious Disorders - Drug Targets, 2006
- NM 283, AN EFFICIENT PRODRUG OF THE POTENT ANTI-HCV AGENT 2′-C-METHYLCYTIDINENucleosides, Nucleotides & Nucleic Acids, 2005
- A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12American Journal of Epidemiology, 1938